{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:14:25Z","timestamp":1788365665205,"version":"build-2803163510"},"reference-count":113,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.pt.2026.07.004","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:36:56Z","timestamp":1785382616000},"page":"861-875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Malaria and cancer: common features and interactions"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3246-3248","authenticated-orcid":false,"given":"Xin-zhuan","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1049-1638","authenticated-orcid":false,"given":"Rachel V.","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0964-5685","authenticated-orcid":false,"given":"Awet A.","family":"Teklemichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3285-832X","authenticated-orcid":false,"given":"Fangzheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5784-6160","authenticated-orcid":false,"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2026.07.004_bb0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.canlet.2017.01.022","article-title":"Redirecting the focus of cancer immunotherapy to premalignant conditions","volume":"391","author":"Young","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.pt.2026.07.004_bb0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0092-8674(95)90055-1","article-title":"The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes","volume":"82","author":"Su","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.pt.2026.07.004_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0020022","article-title":"Mutually exclusive expression of virulence genes by malaria parasites is regulated independently of antigen production","volume":"2","author":"Dzikowski","year":"2006","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2026.07.004_bb0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0092-8674(95)90056-X","article-title":"Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes","volume":"82","author":"Smith","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.pt.2026.07.004_bb0025","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1126\/science.272.5267.1502","article-title":"Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta","volume":"272","author":"Fried","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.pt.2026.07.004_bb0030","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.20041579","article-title":"Evidence for the involvement of VAR2CSA in pregnancy-associated malaria","volume":"200","author":"Salanti","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.pt.2026.07.004_bb0035","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1038\/s41467-021-23254-1","article-title":"Cryo-EM reveals the architecture of placental malaria VAR2CSA and provides molecular insight into chondroitin sulfate binding","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pt.2026.07.004_bb0040","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/cid\/ciy1140","article-title":"First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria","volume":"69","author":"Mordmuller","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2026.07.004_bb0045","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ccell.2015.09.003","article-title":"Targeting human cancer by a glycosaminoglycan binding malaria protein","volume":"28","author":"Salanti","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pt.2026.07.004_bb0050","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.3390\/ijms21072401","article-title":"Optimization of rVAR2-based isolation of cancer cells in blood for building a robust assay for clinical detection of circulating tumor cells","volume":"21","author":"Sand","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pt.2026.07.004_bb0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/vaccines6010013","article-title":"The emerging role of pattern recognition receptors in the pathogenesis of malaria","volume":"6","author":"Kalantari","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.pt.2026.07.004_bb0060","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1038\/onc.2016.104","article-title":"Damage-associated molecular patterns in cancer: a double-edged sword","volume":"35","author":"Hernandez","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.pt.2026.07.004_bb0065","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/s13071-024-06529-6","article-title":"Role of inflammasomes in Toxoplasma and Plasmodium infections","volume":"17","author":"Wang","year":"2024","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.pt.2026.07.004_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.839041","article-title":"Inflammasomes in cancer progression and anti-tumor immunity","volume":"10","author":"Lillo","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.pt.2026.07.004_bb0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1475-2875-5-85","article-title":"Human malarial disease: a consequence of inflammatory cytokine release","volume":"5","author":"Clark","year":"2006","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2026.07.004_bb0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ccell.2024.11.011","article-title":"Cytokines in cancer","volume":"43","author":"Kureshi","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pt.2026.07.004_bb0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41577-019-0158-z","article-title":"T cell-mediated immunity to malaria","volume":"19","author":"Kurup","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.pt.2026.07.004_bb0090","doi-asserted-by":"crossref","DOI":"10.4110\/in.2023.23.e41","article-title":"The role of CD4 T cell help in CD8 T cell differentiation and function during chronic infection and cancer","volume":"23","author":"Topchyan","year":"2023","journal-title":"Immune Netw."},{"key":"10.1016\/j.pt.2026.07.004_bb0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.apar.2024.02.001","article-title":"PfEMP1 and var genes \u2013 still of key importance in Plasmodium falciparum malaria pathogenesis and immunity","volume":"125","author":"Hviid","year":"2024","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.pt.2026.07.004_bb0100","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.pt.2026.07.004_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.70196","article-title":"Immune checkpoint molecules: a review on pathways and immunotherapy implications","volume":"13","author":"Rezazadeh-Gavgani","year":"2025","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.pt.2026.07.004_bb0110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/cei\/uxae015","article-title":"Chronic malaria exposure is associated with inhibitory markers on T cells that correlate with atypical memory and marginal zone-like B cells","volume":"216","author":"Mitchell","year":"2024","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.pt.2026.07.004_bb0115","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00345-24","article-title":"Synergistic blockade of TIGIT and PD-L1 increases type-1 inflammation and improves parasite control during murine blood-stage Plasmodium yoelii non-lethal infection","volume":"92","author":"Dookie","year":"2024","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pt.2026.07.004_bb0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fmicb.2014.00249","article-title":"Malaria drives T cells to exhaustion","volume":"5","author":"Wykes","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.pt.2026.07.004_bb0125","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.immuni.2005.08.006","article-title":"Upregulation of TGF-\u03b2, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection","volume":"23","author":"Walther","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.pt.2026.07.004_bb0130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fimmu.2019.00229","article-title":"The role of IL-10 in malaria: a double edged sword","volume":"10","author":"Kumar","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pt.2026.07.004_bb0135","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211069012","article-title":"Tumor promoting roles of IL-10, TGF-\u03b2, IL-4, and IL-35: its implications in cancer immunotherapy","volume":"10","author":"Mirlekar","year":"2022","journal-title":"SAGE Open Med."},{"key":"10.1016\/j.pt.2026.07.004_bb0140","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1128\/IAI.00261-12","article-title":"Interleukin-10 (IL-10) polymorphisms are associated with IL-10 production and clinical malaria in young children","volume":"80","author":"Zhang","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pt.2026.07.004_bb0145","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.pt.2014.02.001","article-title":"The proliferating cell hypothesis: a metabolic framework for Plasmodium growth and development","volume":"30","author":"Salcedo-Sora","year":"2014","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2026.07.004_bb0150","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","article-title":"Aerobic glycolysis: meeting the metabolic requirements of cell proliferation","volume":"27","author":"Lunt","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.pt.2026.07.004_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009122","article-title":"Etiology of lactic acidosis in malaria","volume":"17","author":"Possemiers","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2026.07.004_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021237","article-title":"Antimalarial activity of potential inhibitors of Plasmodium falciparum lactate dehydrogenase enzyme selected by docking studies","volume":"6","author":"Penna-Coutinho","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2026.07.004_bb0165","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1158\/0008-5472.CAN-19-0217","article-title":"Targeting glycolysis through inhibition of lactate dehydrogenase impairs tumor growth in preclinical models of Ewing sarcoma","volume":"79","author":"Yeung","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.pt.2026.07.004_bb0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12964-019-0332-8","article-title":"Low levels of pyruvate induced by a positive feedback loop protects cholangiocarcinoma cells from apoptosis","volume":"17","author":"Zhang","year":"2019","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.pt.2026.07.004_bb0175","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1021\/acs.jproteome.5c00742","article-title":"Exploratory serum metabolomic profiling of asymptomatic malaria children infected with Plasmodium falciparum in Tanzania","volume":"25","author":"Zinga","year":"2026","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.pt.2026.07.004_bb0180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12936-019-2733-y","article-title":"Does reduced oxygen delivery cause lactic acidosis in falciparum malaria? An observational study","volume":"18","author":"Kingston","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2026.07.004_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.114251","article-title":"Temporal multi-tissue profiling reveals metabolites linked to immune response and malaria parasitemia control","volume":"29","author":"Teklemichael","year":"2026","journal-title":"iScience"},{"key":"10.1016\/j.pt.2026.07.004_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.649184","article-title":"How malaria parasites acquire nutrients from their host","volume":"9","author":"Counihan","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.pt.2026.07.004_bb0195","article-title":"Genetic analysis of pyrimidine biosynthetic enzymes in Plasmodium falciparum","author":"Rajaram","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.pt.2026.07.004_bb0200","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/AAC.34.7.1393","article-title":"In vitro susceptibilities of Plasmodium falciparum to compounds which inhibit nucleotide metabolism","volume":"34","author":"Queen","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2026.07.004_bb0205","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","article-title":"Nucleotide metabolism: a pan-cancer metabolic dependency","volume":"23","author":"Mullen","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.pt.2026.07.004_bb0210","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1073\/pnas.1507228112","article-title":"MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism","volume":"112","author":"Shroff","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2026.07.004_bb0215","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1073\/pnas.1516544112","article-title":"Targeting glutamine metabolism rescues mice from late-stage cerebral malaria","volume":"112","author":"Gordon","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2026.07.004_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008930","article-title":"Insights into malaria pathogenesis gained from host metabolomics","volume":"16","author":"Colvin","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2026.07.004_bb0225","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1038\/s41598-019-43044-6","article-title":"Amino acid derangements in adults with severe falciparum malaria","volume":"9","author":"Leopold","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pt.2026.07.004_bb0230","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13046-025-03502-8","article-title":"Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma","volume":"44","author":"Hanssen","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.pt.2026.07.004_bb0235","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1016\/j.apsb.2024.04.021","article-title":"Phenylalanine deprivation inhibits multiple myeloma progression by perturbing endoplasmic reticulum homeostasis","volume":"14","author":"Cheng","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.pt.2026.07.004_bb0240","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1158\/0008-5472.CAN-12-0569","article-title":"Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion","volume":"72","author":"Platten","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.pt.2026.07.004_bb0245","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","article-title":"Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer","volume":"31","author":"Snaebjornsson","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.pt.2026.07.004_bb0250","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1286-4579(03)00070-4","article-title":"Lipid metabolism in Plasmodium falciparum-infected erythrocytes: possible new targets for malaria chemotherapy","volume":"5","author":"Mitamura","year":"2003","journal-title":"Microbes Infect."},{"key":"10.1016\/j.pt.2026.07.004_bb0255","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1462-5822.2008.01270.x","article-title":"Type II fatty acid synthesis is essential only for malaria parasite late liver stage development","volume":"11","author":"Vaughan","year":"2009","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.pt.2026.07.004_bb0260","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/1475-2875-12-442","article-title":"Serum lipids and lipoproteins in malaria \u2013 a systematic review and meta-analysis","volume":"12","author":"Visser","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2026.07.004_bb0265","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/jrms.jrms_267_22","article-title":"The tangled web of dyslipidemia and cancer: is there any association?","volume":"27","author":"Neshat","year":"2022","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.pt.2026.07.004_bb0270","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1007\/s00432-021-03867-1","article-title":"Low blood levels of high-density lipoprotein (HDL) cholesterol are positively associated with cancer","volume":"148","author":"Loosen","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.pt.2026.07.004_bb0275","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1158\/2159-8290.CD-18-0706","article-title":"PPT1 promotes tumor growth and is the molecular target of chloroquine derivatives in cancer","volume":"9","author":"Rebecca","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.pt.2026.07.004_bb0280","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3390\/ijms25031410","article-title":"Mechanism of DNA intercalation by chloroquine provides insights into toxicity","volume":"25","author":"Joshi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pt.2026.07.004_bb0285","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/j.drudis.2020.09.010","article-title":"Chloroquine against malaria, cancers and viral diseases","volume":"25","author":"Zhou","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.pt.2026.07.004_bb0290","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3332\/ecancer.2017.781","article-title":"Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents","volume":"11","author":"Verbaanderd","year":"2017","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.pt.2026.07.004_bb0295","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.3390\/molecules24193604","article-title":"Ferrocene-based compounds with antimalaria\/anticancer activity","volume":"24","author":"Peter","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.pt.2026.07.004_bb0300","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.3390\/molecules29163886","article-title":"Artemisinin and its derivatives as potential anticancer agents","volume":"29","author":"Wen","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.pt.2026.07.004_bb0305","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13045-018-0561-0","article-title":"Artesunate shows potent anti-tumor activity in B-cell lymphoma","volume":"11","author":"Vatsveen","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.pt.2026.07.004_bb0310","article-title":"Artemisinin suppresses aerobic glycolysis in thyroid cancer cells by downregulating HIF-1a, which is increased by the XIST\/miR-93\/HIF-1a pathway","volume":"18","author":"Yang","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2026.07.004_bb0315","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1016\/j.micinf.2006.07.011","article-title":"Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations","volume":"8","author":"Musset","year":"2006","journal-title":"Microbes Infect."},{"key":"10.1016\/j.pt.2026.07.004_bb0320","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1158\/1078-0432.CCR-20-4128","article-title":"Mitochondrial inhibitor atovaquone increases tumor oxygenation and inhibits hypoxic gene expression in patients with non-small cell lung cancer","volume":"27","author":"Skwarski","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.pt.2026.07.004_bb0325","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1158\/1535-7163.MCT-18-1286","article-title":"Atovaquone: an antiprotozoal drug suppresses primary and resistant breast tumor growth by inhibiting HER2\/\u03b2-catenin signaling","volume":"18","author":"Gupta","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.pt.2026.07.004_bb0330","doi-asserted-by":"crossref","first-page":"34084","DOI":"10.18632\/oncotarget.9122","article-title":"Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells","volume":"7","author":"Fiorillo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.pt.2026.07.004_bb0335","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008554","article-title":"Mefloquine enhances the efficacy of anti-PD-1 immunotherapy via IFN-\u03b3-STAT1-IRF1-LPCAT3-induced ferroptosis in tumors","volume":"12","author":"Tao","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.pt.2026.07.004_bb0340","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pt.2009.12.002","article-title":"Anticancer agents against malaria: time to revisit?","volume":"26","author":"Nzila","year":"2010","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2026.07.004_bb0345","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM194806032382301","article-title":"Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid","volume":"238","author":"Farber","year":"1948","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pt.2026.07.004_bb0350","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/infdis\/jiq024","article-title":"Methotrexate is highly potent against pyrimethamine-resistant Plasmodium vivax","volume":"203","author":"Imwong","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2026.07.004_bb0355","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.det.2015.05.009","article-title":"Methotrexate and pralatrexate","volume":"33","author":"Wood","year":"2015","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.pt.2026.07.004_bb0360","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1128\/AAC.00308-09","article-title":"In vitro activity of antifolate and polymorphism in dihydrofolate reductase of Plasmodium falciparum isolates from the Kenyan coast: emergence of parasites with Ile-164-Leu mutation","volume":"53","author":"Kiara","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2026.07.004_bb0365","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40794-025-00257-0","article-title":"The emerging role of Imatinib in malaria management: a review of evidence and future directions","volume":"11","author":"Ajekiigbe","year":"2025","journal-title":"Trop. Dis. Travel Med. Vaccines"},{"key":"10.1016\/j.pt.2026.07.004_bb0370","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/s41598-020-59298-4","article-title":"Epigenetic inhibitors target multiple stages of Plasmodium falciparum parasites","volume":"10","author":"Coetzee","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pt.2026.07.004_bb0375","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo7219","article-title":"The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple Plasmodium kinases and life cycle stages","volume":"14","author":"Arendse","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pt.2026.07.004_bb0380","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1472-6904-7-13","article-title":"Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3B","volume":"7","author":"Reynolds","year":"2007","journal-title":"BMC Clin. Pharmacol."},{"key":"10.1016\/j.pt.2026.07.004_bb0385","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aea2531","article-title":"Adjunctive ruxolitinib attenuates inflammation and enhances immunity in volunteers experimentally infected with Plasmodium falciparum","volume":"17","author":"Webster","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pt.2026.07.004_bb0390","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/nyas.12662","article-title":"The molecular basis of antifolate resistance in Plasmodium falciparum: looking beyond point mutations","volume":"1342","author":"Heinberg","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pt.2026.07.004_bb0395","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5732\/cjc.011.10466","article-title":"Role of ABC transporters in cancer chemotherapy","volume":"31","author":"Sun","year":"2012","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.pt.2026.07.004_bb0400","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ijpara.2010.04.001","article-title":"Transporters as mediators of drug resistance in Plasmodium falciparum","volume":"40","author":"Sanchez","year":"2010","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2026.07.004_bb0405","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.chembiol.2021.06.006","article-title":"The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance","volume":"29","author":"Murithi","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.pt.2026.07.004_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012853","article-title":"Malaria: factors affecting disease severity, immune evasion mechanisms, and reversal of immune inhibition to enhance vaccine efficacy","volume":"21","author":"Su","year":"2025","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2026.07.004_bb0415","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pt.2026.07.004_bb0420","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41568-021-00336-2","article-title":"Genetic and non-genetic clonal diversity in cancer evolution","volume":"21","author":"Black","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.pt.2026.07.004_bb0425","doi-asserted-by":"crossref","DOI":"10.1097\/BS9.0000000000000270","article-title":"The tumor microenvironment in hematologic malignancies: immune evasion, metabolic reprogramming, and therapeutic resistance","volume":"8","author":"Walid","year":"2026","journal-title":"Blood Sci."},{"key":"10.1016\/j.pt.2026.07.004_bb0430","first-page":"166","article-title":"Burkitt\u2019s lymphoma in Africa, a review of the epidemiology and etiology","volume":"7","author":"Orem","year":"2007","journal-title":"Afr. Health Sci."},{"key":"10.1016\/j.pt.2026.07.004_bb0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005331","article-title":"The link between Plasmodium falciparum malaria and endemic Burkitt\u2019s lymphoma\u2014new insight into a 50-year-old enigma","volume":"12","author":"Thorley-Lawson","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2026.07.004_bb0440","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nrmicro1089","article-title":"Endemic Burkitt\u2019s lymphoma: a polymicrobial disease?","volume":"3","author":"Rochford","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.pt.2026.07.004_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004170","article-title":"A multifactorial role for P. falciparum malaria in endemic Burkitt\u2019s lymphoma pathogenesis","volume":"10","author":"Torgbor","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2026.07.004_bb0450","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cell.2015.07.019","article-title":"Plasmodium infection promotes genomic instability and AID-dependent B cell lymphoma","volume":"162","author":"Robbiani","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.pt.2026.07.004_bb0455","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13027-017-0117-x","article-title":"Worldwide malaria incidence and cancer mortality are inversely associated","volume":"12","author":"Qin","year":"2017","journal-title":"Infect. Agent. Cancer"},{"key":"10.1016\/j.pt.2026.07.004_bb0460","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13027-021-00370-7","article-title":"Malaria and cancer: a critical review on the established associations and new perspectives","volume":"16","author":"Ellis","year":"2021","journal-title":"Infect. Agent. Cancer"},{"key":"10.1016\/j.pt.2026.07.004_bb0465","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/bioengineering9080395","article-title":"Anti-tumor effect of parasitic protozoans","volume":"9","author":"Ding","year":"2022","journal-title":"Bioengineering (Basel)"},{"key":"10.1016\/j.pt.2026.07.004_bb0470","article-title":"Antitumor effect of malaria parasite infection in a murine Lewis lung cancer model through induction of innate and adaptive immunity","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2026.07.004_bb0475","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12964-020-00570-5","article-title":"Plasmodium infection inhibits tumor angiogenesis through effects on tumor-associated macrophages in a murine implanted hepatoma model","volume":"18","author":"Wang","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.pt.2026.07.004_bb0480","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13071-022-05291-x","article-title":"Plasmodium infection suppresses colon cancer growth by inhibiting proliferation and promoting apoptosis associated with disrupting mitochondrial biogenesis and mitophagy in mice","volume":"15","author":"Yao","year":"2022","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.pt.2026.07.004_bb0485","article-title":"Plasmodium infection fully activates the immune system in peripheral blood and tumor microenvironment in a murine Lewis lung cancer model","volume":"12","author":"Huang","year":"2025","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.pt.2026.07.004_bb0490","first-page":"1371","article-title":"Association between malaria incidence and all cancer mortality in fifty U.S. States and the District of Columbia","volume":"30","author":"Lehrer","year":"2010","journal-title":"Anticancer Res."},{"key":"10.1016\/j.pt.2026.07.004_bb0495","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/ijc.10384","article-title":"Grade of malignancy of cervical cancer in regions of Uganda with varying malarial endemicity","volume":"99","author":"Odida","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.pt.2026.07.004_bb0500","article-title":"Malaria driven mechanisms shaping cancer risk and aggressiveness in African populations","volume":"48","author":"Udobi","year":"2026","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.pt.2026.07.004_bb0505","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3390\/v16111723","article-title":"Prevalence, risk factors, and clinical profiles of hepatitis D virus in Nigeria: a systematic review","volume":"16","author":"Adepoju","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.pt.2026.07.004_bb0510","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3390\/cancers15020533","article-title":"Hepatitis virus and hepatocellular carcinoma: recent advances","volume":"15","author":"Shen","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pt.2026.07.004_bb0515","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180127","article-title":"Cancer-malaria: hidden connections","volume":"8","author":"Nordor","year":"2018","journal-title":"Open Biol."},{"key":"10.1016\/j.pt.2026.07.004_bb0520","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0014-5793(01)02370-5","article-title":"Duffy-null promoter heterozygosity reduces DARC expression and abrogates adhesion of the P. vivax ligand required for blood-stage infection","volume":"495","author":"Michon","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.pt.2026.07.004_bb0525","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1126\/science.7689250","article-title":"A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor","volume":"261","author":"Horuk","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.pt.2026.07.004_bb0530","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/08820130802191318","article-title":"Chemokine decoy receptors: new players in reproductive immunology","volume":"37","author":"Borroni","year":"2008","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.pt.2026.07.004_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007368","article-title":"Genetic ancestry and population differences in levels of inflammatory cytokines in women: role for evolutionary selection and environmental factors","volume":"14","author":"Yao","year":"2018","journal-title":"PLoS Genet."},{"key":"10.1016\/j.pt.2026.07.004_bb0540","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.587933","article-title":"Host-malaria parasite interactions and impacts on mutual evolution","volume":"10","author":"Su","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.pt.2026.07.004_bb0545","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41419-021-03611-0","article-title":"Development of a bispecific immune engager using a recombinant malaria protein","volume":"12","author":"Nordmaj","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.pt.2026.07.004_bb0550","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/s41467-018-05793-2","article-title":"The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner","volume":"9","author":"Agerbaek","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pt.2026.07.004_bb0555","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau1458","article-title":"Challenges and strategies for developing efficacious and long-lasting malaria vaccines","volume":"11","author":"Beeson","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pt.2026.07.004_bb0560","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41591-026-04241-9","article-title":"Clinical development of cancer vaccines","volume":"32","author":"Haanen","year":"2026","journal-title":"Nat. Med."},{"key":"10.1016\/j.pt.2026.07.004_bb0565","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.3390\/cancers11111756","article-title":"Targeting negative and positive immune checkpoints with monoclonal antibodies in therapy of cancer","volume":"11","author":"Marhelava","year":"2019","journal-title":"Cancers (Basel)"}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149222600200X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149222600200X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:17:58Z","timestamp":1788362278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147149222600200X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":113,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S147149222600200X"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2026.07.004","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malaria and cancer: common features and interactions","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2026.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}